These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12906014)

  • 1. Clinical Trials in Cancer-SMi Conference. 11-12 June 2003, London, UK.
    Maneely D
    IDrugs; 2003 Jul; 6(7):650-1. PubMed ID: 12906014
    [No Abstract]   [Full Text] [Related]  

  • 2. 9-Aminocamptothecin and beyond. Preclinical and clinical studies.
    Potmesil M; Arbuck SG; Takimoto CH; Liebes L; Hochster H
    Ann N Y Acad Sci; 1996 Dec; 803():231-46. PubMed ID: 8993517
    [No Abstract]   [Full Text] [Related]  

  • 3. Gimatecan (sigma-tau industrie farmaceutiche riunite/novartis).
    Nitiss JL; Nitiss KC
    IDrugs; 2005 Jul; 8(7):578-88. PubMed ID: 15973567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diflomotecan. Ipsen.
    Osheroff N
    IDrugs; 2004 Mar; 7(3):257-63. PubMed ID: 15011101
    [No Abstract]   [Full Text] [Related]  

  • 6. Current treatment options for advanced colorectal cancer.
    Rougier P; Mitry E
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):30-3. PubMed ID: 11049030
    [No Abstract]   [Full Text] [Related]  

  • 7. CPT-11: a novel antitumor drug.
    Armand JP
    Jpn J Cancer Res; 1994 Aug; 85(8):inside front cover. PubMed ID: 7928619
    [No Abstract]   [Full Text] [Related]  

  • 8. Highlights from the International Conference on Molecular Targets and Cancer Therapeutics: Discovery, Biology, And Clinical Applications, Philadelphia, PA, November 2005; ECCO 13--The European Cancer Conference, Paris, France, October 30-November 3, 2005.
    Reddy K; D'Orazio A
    Clin Genitourin Cancer; 2005 Dec; 4(3):156-9. PubMed ID: 16425983
    [No Abstract]   [Full Text] [Related]  

  • 9. [Irinotecan hydrochloride (CPT-11)].
    Furue H
    Gan To Kagaku Ryoho; 1994 Apr; 21(5):709-17. PubMed ID: 8154899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I/IIA randomized study of PHY906, a novel herbal agent, as a modulator of chemotherapy in patients with advanced colorectal cancer.
    Farrell MP; Kummar S
    Clin Colorectal Cancer; 2003 Feb; 2(4):253-6. PubMed ID: 12620148
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials referral resource. Clinical trials with topotecan.
    Cheson BD; Arbuck SG
    Oncology (Williston Park); 1993 Feb; 7(2):49-51. PubMed ID: 8439468
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical trials referral resource. Trials of topotecan.
    Cheson BD; Phillips PH; Arbuck SG
    Oncology (Williston Park); 1995 Mar; 9(3):220, 224-6, 228. PubMed ID: 7669515
    [No Abstract]   [Full Text] [Related]  

  • 13. Phacilitate Cell and Gene Therapy Forum 2005. Cell and gene therapy: a corporate perspective. 24-26 January 2005, Washington, DC, USA.
    Salmons B
    IDrugs; 2005 Mar; 8(3):203-5. PubMed ID: 15772888
    [No Abstract]   [Full Text] [Related]  

  • 14. Response rate is associated with prolonged survival in patients with advanced non-small cell lung cancer treated with gefitinib or erlotinib.
    Tsujino K; Kawaguchi T; Kubo A; Aono N; Nakao K; Koh Y; Tachibana K; Isa S; Takada M; Kurata T
    J Thorac Oncol; 2009 Aug; 4(8):994-1001. PubMed ID: 19633474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A rapid and systematic review of the evidence for the clinical effectiveness and cost-effectiveness of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer.
    Lloyd Jones M; Hummel S; Bansback N; Orr B; Seymour M
    Health Technol Assess; 2001; 5(25):1-128. PubMed ID: 11990245
    [No Abstract]   [Full Text] [Related]  

  • 16. Rubitecan: 9-NC, 9-Nitro-20(S)-camptothecin, 9-nitro-camptothecin, 9-nitrocamptothecin, RFS 2000, RFS2000.
    Drugs R D; 2004; 5(5):305-11. PubMed ID: 15357630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erlotinib hydrochloride.
    Dowell J; Minna JD; Kirkpatrick P
    Nat Rev Drug Discov; 2005 Jan; 4(1):13-4. PubMed ID: 15690599
    [No Abstract]   [Full Text] [Related]  

  • 18. [Molecular biology methods in cancer medicine: options beyond steel instrument, ray and chemotherapy].
    Paukstadt W
    MMW Fortschr Med; 2004 Nov; 146(47):12, 14. PubMed ID: 15624648
    [No Abstract]   [Full Text] [Related]  

  • 19. [Topoisomerase I inhibitors. Review of phase II trials with irinotecan (CPT-11) and topotecan].
    Bonneterre J
    Bull Cancer; 1995 Aug; 82(8):623-8. PubMed ID: 7492818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topotecan demonstrates significant activity in small-cell lung cancer.
    Oncology (Williston Park); 1996 Mar; 10(3):422-3. PubMed ID: 8820456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.